DELFI Diagnostics Hires David Morgenstern, PhD, as Vice President of Clinical Development
BALTIMORE and PALO ALTO, Calif., June 1, 2023 /PRNewswire/ -- DELFI Diagnostics, a pioneering developer of a new class of high-performance, accessible liquid biopsy tests for early cancer detection and monitoring, has hired Dave Morgenstern, PhD, as Vice President of Clinical Development.
- BALTIMORE and PALO ALTO, Calif., June 1, 2023 /PRNewswire/ -- DELFI Diagnostics, a pioneering developer of a new class of high-performance, accessible liquid biopsy tests for early cancer detection and monitoring, has hired Dave Morgenstern, PhD, as Vice President of Clinical Development.
- Dave joins DELFI from Roche Diagnostics, where he spent more than a decade in clinical development roles focused on oncology screening and diagnostic products, most recently as Global Head of Clinical Development for Oncology and Genetics.
- "I am very excited to add Dave's experience developing oncology diagnostics and therapeutics to DELFI's leadership team," said Victor Velculescu, MD, PhD, DELFI's Founder and CEO.
- "I am excited to help develop the clinical evidence that will support the DELFI platform's use in multiple applications."